Financhill
Back

Keros Therapeutics Stock Predictions

S&P Global: Private Equity Invests $36 Billion Into What?

Read More
Sell
43

KROS
Keros Therapeutics

Last Price:
64.62
Seasonality Move:
-23.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Biden's Oil War: The Administration Is All-In on Green Energy.

Download Free Report

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 6.6% based on the past 3 years of stock performance.
  • Keros Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $64.59. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 6.6% based on the past 3 years of stock performance.

Keros Therapeutics Stock Rating

Sell
43
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • The current trend is moderately bearish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.02

Prediction Charts

Market Cap:
2.32B
Price in USD:
64.59
Volume:
436.22K
Beta:
1.17

Technical Analysis

SMA50:
61.19
SMA100:
48.54
SMA200:
42.19
52-Wk Change:
54.78%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 64.59 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-8 69.68 70.55 71.29 69.14
Mar-11 69.90 66.31 70.58 65.75
Mar-12 66.36 67.54 69.69 65.78
Mar-13 67.68 67.77 69.63 66.80
Mar-14 67.02 64.87 67.25 63.64
Mar-15 64.24 67.35 68.30 64.24
Mar-18 66.93 63.79 67.12 63.62
Mar-19 63.58 64.20 65.06 62.79
Mar-20 64.03 66.99 67.00 63.24
Mar-21 67.65 68.92 69.89 66.85
Mar-22 69.26 65.86 69.26 65.36
Mar-25 65.52 66.26 67.42 65.52
Mar-26 67.27 66.12 67.49 65.22
Mar-27 59.20 64.59 65.86 59.14

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.